AbCellera Biologics Inc.
ABCL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703057
In the last 90 days, AbCellera Biologics Inc. insiders filed 4 open-market purchases and 0 sales; 150 institutions reported holding it in 13F filings for Q2 2026, worth $908.8M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding AbCellera Biologics Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 138 | 150 | +12 |
| Shares | 124.3M | 116.1M | −8.19M (−6.6%) |
| Value | $434.0M | $908.8M | +$474.8M (+109.4%) |
New holders (39)
Institutions that held AbCellera Biologics Inc. at the end of Q2 2026 but not at the end of Q1 2026.
Sold out (27)
Institutions that held AbCellera Biologics Inc. at the end of Q1 2026 and filed for Q2 2026 without it.